Cholangiocarcinoma (M8160/3) liver 155.1 unspecified site 155.1 Cystadenocarcinoma (M8440/3) - see also Neoplasm, by site, malignant bile duct type (M8161/3) 155.1 155.0 ICD9Data.com 155.2 ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions.
Full Answer
The diagnosis of cholangiocarcinoma remains difficult, despite the multiple diagnostic methods available. Further studies comparing the accuracy of the various imaging methods, especially the new intraductal methods, are needed, and the imaging features of malignancy should be standardized.
Cholangiocarcinoma (CCA) sub-types: Intrahepatic/ Perihilar/ Extrahepatic 50-60% “Perihilar”: arise at bifurcation of main ducts, pCCA 20-30% distal CBD, dCCA 10-20% arise in intrahepatic ducts, iCCA pCCA, dCCA, iCCA have distinct epidemiology, pathobiology and management
The value of tumor markers in the diagnosis of cholangiocarcinomas remains controversial. The most commonly used markers are carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA).
Rather than being useful for the diagnosis of cholangiocarcinoma, PET (PET/CT) is particularly valuable in detecting unsuspected distant metastases 71. Characterization of proximal biliary stenoses
Cholangiocarcinoma combined with hepatocellular carcinoma is classified to code 155.0. • Hepatoblastoma (155.0) may be caused by an abnormal gene. This type affects children younger than the age of 4. • Angiosarcoma (155.0) or hemangiosarcoma (155.0) begins in the blood vessels of the liver. Benign Liver Tumors.
Secondary liver cancer, also called metastasis to the liver, is classified to code 197.7. If liver cancer is documented with no further specification stating primary or secondary, assign code 155.2. It is appropriate to query the physician for clarification if the cancer is not specified as primary or metastatic.
Thin needles are inserted into the tumor and heated with an electric current. Open ablation of the liver is classified to code 50.23. Code 50.24 identifies percutaneous ablation of the liver. Code 50.25 is for laparoscopic ablation of the liver, and other and unspecified ablation of the liver goes to 50.26.
Benign Liver Tumors. The following are types of benign liver tumors: • Hemangioma (228.04) most commonly affects the liver’s blood vessels. • Hepatic adenoma (211.5) originates in hepatocytes and may be caused by birth control pills. • Focal nodular hyperplasia is a combination of several types of cells.
Liver cancer, also documented as primary liver cancer or hepatoma, is usually caused by cirrhosis or scarring of the liver, which may be due to alcohol abuse, autoimmune diseases of the liver, hepatitis B or C, or hemochromatosis. Typically, cancer found in the liver has metastasized there from another part of the body.
The following are types of primary liver cancer: • Hepatocellular carcinoma (155.0), the most common form, starts in the hepatocytes. • Cholangiocarcinoma (155.1) begins in small bile ducts in the liver. Cholangiocarcinoma combined with hepatocellular carcinoma is classified to code 155.0.